Telstra Health, Friday announced a key development in its global health analytics capability with confirmation of its acquisition of the UK based firm Dr Foster, a leading provider of healthcare variation analysis and clinical benchmarking solutions. The move is seen to be aligned with Telstra's strategy to create a more connected health care system and to position itself as a leading provider of integrated eHealth solutions.
Dr Foster works with healthcare organisations to achieve sustainable improvements in their performance through better use of data. It uses risk adjusted methodologies to compare the outcomes of individual hospital patients, allowing adjustment for individual factors such as medical history, age or other background factors. Telstra Health had previously secured the exclusive rights to provide Dr Foster products and services in Australia in December 2013, with agreements now in place with 15 health services in Australia.
Roger Taylor, Co-Founder & Director of Research and Public Affairs, Dr Foster
This is a really exciting development for Dr Foster. Telstra Health brings the resources, scale and expertise to help us take the company forward and maximise the opportunities that in information driven health system can provide for patients.
Shane Solomon, Health Managing Director, Telstra
We’re delighted to acquire Dr Foster. We have had a successful relationship as the exclusive reseller of Dr Foster in Australia and when the opportunity arose to purchase the company we saw it as a logical next step, acquiring not only a leading and innovative business but also the experience and skills that will help us compete on the global stage.